Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States

por Belletti, Daniel A, Zacker, Christopher, Wogen, Jenifer
Publicado 2010

An Economic Analysis: Is Fidaxomicin Worth the Cost?

por Shah, Hemal, Doyle, Joseph J., Belletti, Daniel A.
Publicado 2014

Potential value of electronic prescribing in health economic and outcomes research

por Cooke, Catherine E, Isetts, Brian J, Sullivan, Thomas E, Fustgaard, Maren, Belletti, Daniel A
Publicado 2010

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement

por Peasah, Samuel K., Huang, Yan, Venditto, John, Brekosky, Robert, Belletti, Daniel, Campbell, Vanessa, Manolis, Chronis, Good, Chester B.
Publicado 2023

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry

por Salter, Amber R, Marrie, Ruth Ann, Agashivala, Neetu, Belletti, Daniel A, Kim, Edward, Cutter, Gary R, Cofield, Stacey S, Tyry, Tuula
Publicado 2014

Elaborate biologic approval process delays care of patients with moderate-to-severe asthma

por Sehanobish, Esha, Ye, Kenny, Imam, Kamran, Sariahmed, Karim, Kurian, Joshua, Patel, Jalpa, Belletti, Daniel, Chung, Yen, Jariwala, Sunit, White, Andrew, Jerschow, Elina
Publicado 2023

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

por Nair, Kavita V, Belletti, Daniel A, Doyle, Joseph J, Allen, Richard R, McQueen, Robert B, Saseen, Joseph J, Vande Griend, Joseph, Patel, Jay V, McQueen, Angela, Jan, Saira
Publicado 2011